HOXC6 might be a key factor in promoting tumorigenesis and glioma progression by regulating the EMT signaling pathway and might represent a novel immune therapeutic target in gliomas (Yu et al., 2021; Arunachalam et al., 2022; Huang et al., 2022). Here, HOXC6 is linked to glioma.